King III Content Reviewer Celonova Biosciences None None Merck (DSMB) Wyeth (DSMB) None None Frederick G. Kushner Content Reviewer None None None Novartis None None David J. Maron Content Reviewer None None Cardiovascular Care Affiliates* None None Plaintiff, acute coronary syndrome, Douglass A. Morrison Content Reviewer None None None None None None (Continued) Appendix 2. Continued Peer Reviewer Representation Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Thomas C. Piemonte Content Reviewer ACCF Board of Governors None None None None None Defendant, stent perforation, Peter K. Smith Content Reviewer Eli Lilly None None None None None Sidney C. Smith Content Reviewer None None None None None None Richard W. Snyder Content Reviewer ACCF Board of Governors None None None None Hospital Corporation of America None Patrick L. Whitlow Content Reviewer Edwards Lifesciences* eValve* Medtronic* None None None ICON None David O. Williams Content Reviewer Light Lab/St. Jude Medical None None None None None R. Scott Wright Content Reviewer Hoffman LaRoche* None None None None None This table represents the relationships of reviewers with industry and other entities that were disclosed at the time of peer review and determined to be relevant. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% of the voting stock or share of the business entity, or ownership of $10 000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person s gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. 